Anhui Wanbang Pharmaceutical Technology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Why is Anhui Wanbang Pharmaceutical Technology Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -4.30% and Operating profit at -132.73% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 14.13% signifying low profitability per unit of shareholders funds

With a fall in Net Sales of -41.11%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
RAW MATERIAL COST(Y) Grown by 45.18% (YoY)
NET SALES(Q) Lowest at CNY 62.24 MM
OPERATING PROFIT(Q) Lowest at CNY -7.33 MM

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 15.45% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -0.52% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Anhui Wanbang Pharmaceutical Technology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

-0.55%

-0.12

37.15%

China Shanghai Composite

15.45%

1.03

14.98%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.30%

EBIT Growth (5y)

-132.73%

EBIT to Interest (avg)

52.74

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.77

Sales to Capital Employed (avg)

0.29

Tax Ratio

1.68%

Dividend Payout Ratio

27.25%

Pledged Shares

Institutional Holding

ROCE (avg)

15.15%

ROE (avg)

14.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.44

EV to EBIT

-32.56

EV to EBITDA

-14.55

EV to Capital Employed

-1.58

EV to Sales

-1.54

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

3.41%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-32What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 45.18% (YoY

NET SALES(Q)

Lowest at CNY 62.24 MM

OPERATING PROFIT(Q)

Lowest at CNY -7.33 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -11.78 %

PRE-TAX PROFIT(Q)

Lowest at CNY 0.45 MM

NET PROFIT(Q)

Lowest at CNY 1.5 MM

EPS(Q)

Lowest at CNY 0.1

Here's what is not working for Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Net Sales

At CNY 62.24 MM has Fallen at -41.11%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 0.45 MM has Fallen at -97.15%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 1.5 MM has Fallen at -89.78%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 62.24 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY -7.33 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -11.78 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 0.45 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 1.5 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.1

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Raw Material Cost

Grown by 45.18% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales